- Home
- UPST vs NOVT Comparison
UPST vs NOVT Comparison
Compare UPST & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UPST | NOVT |
|---|---|---|
| Founded | 2012 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.9B |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | UPST | NOVT |
|---|---|---|
| Price | $27.08 | $120.47 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 1 |
| Target Price | $45.50 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 4.5M | 406.8K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 131.25 | N/A |
| EPS | 0.45 | ★ 1.47 |
| Revenue | ★ $1,043,857,000.00 | $521,290,000.00 |
| Revenue This Year | $33.98 | $8.71 |
| Revenue Next Year | $32.48 | $6.47 |
| P/E Ratio | ★ $57.90 | $77.16 |
| Revenue Growth | ★ 63.99 | 35.49 |
| 52 Week Low | $24.93 | $98.27 |
| 52 Week High | $85.31 | $149.95 |
Technical Indicators
Market Signals| Indicator | UPST | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 41.35 |
| Support Level | $25.60 | $111.49 |
| Resistance Level | $50.12 | $126.36 |
| Average True Range (ATR) | 1.53 | 5.89 |
| MACD | 0.48 | -0.82 |
| Stochastic Oscillator | 45.51 | 25.13 |
Price Performance
Historical ComparisonAbout UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.
About NOVT Novanta Inc.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.